메디채널

주메뉴 바로가기
본문 바로가기

기상청 제공

닫기

'김갑성' 기자의 전체기사

Anthill Cloud: Transforming Pharma Marketing with AI, Modular…

COPENHAGEN, Denmark, Nov. 3, 2025 -- Anthill , a leading content excellence and technology partner to the life sciences industry, has announced the launch of Anthill Cloud™ — an innovative platform that combines AI, modular content, and personalized engagement in one connected cloud ecosystem. Designed specifically for Pharma, MedTech, and Biotech, Anthill Cloud unifies content creation, governance, and omnichannel activation, accelerates time-to-market, and elevates HCP engagement. Anthill Cloud brings together three powerful modules: Arcane™ – A
- 김갑성 기자
- 2025-11-03 17:00
Novo Nordisk Launches Wegovy® in Hong Kong for Weight M…

Wegovy® (semaglutide) is a once-weekly injectable prescription medicine used in combination with a reduced calorie diet and increased physical activity for adults and adolescents aged 12 years old or above with obesity or adults with overweight in the presence of at least one related health condition. In Hong Kong, with over 30% of adults classified as obese[1] and 20% of adolescents being overweight or obese[2], Wegovy® offers an effective treatment option to help combat the rising health burden. The launch of Wegovy® in Hong Kong extends Novo Nordisk's commitment to addressin
- 김갑성 기자
- 2025-11-03 16:48
Johnson & Johnson Showcases Latest Advancements in…

Key oral presentations highlight new safety, efficacy and workflow improvements data to optimize irrigation and support consistent procedural outcomes. YOKOHAMA, Japan, Nov. 3, 2025 -- Johnson & Johnson MedTech, a global leader in cardiac arrhythmia treatment1, today announced that new clinical and real-world data from its integrated-by-design VARIPULSE™ Platform in pulsed field ablation (PFA) procedures for atrial fibrillation (AF) will be presented at the Asia Pacific Heart Rhythm Society (APHRS) and the Japanese Heart Rhythm Society (JHRS) joint annual meeting, 12–15 Nov
- 김갑성 기자
- 2025-11-03 14:35
Sandstone Easydrip™ Plus with Hextra Tech™ Hexagonal Bro…

SHANGHAI, Nov. 3, 2025 -- A peer-reviewed article by researchers at the University of Shanghai for Science and Technology (USST), published in an international biomedical engineering journal, reports that the Hextra Tech™ hexagonal, broad-platform hub used in Sandstone Easydrip™ Plus pen needles improves injection stability and user comfort versus conventional narrow hubs in laboratory bench tests. The study measured lower needle deformation and higher anti-tilt resistance under load, attributes that help keep the needle closer to perpendicular for more consistent subcutaneous delivery. These
- 김갑성 기자
- 2025-11-03 14:35
Biomom Reinvents "Snow" with Five-Layer Safety Packaging -- St…

SEOUL, South Korea, Nov. 3, 2025 -- Health supplement brand Biomom has introduced upgraded, hygienic packaging for its flagship probiotic "Biomom Snow." The renewal features five-layer safety stick and pillow packaging designed to enhance probiotic protection and ensure a more convenient, safer experience for consumers. Biomom Snow contains 10 billion CFU probiotics per stick, formulated with 19 MFDS-approved strains, and is enriched with Vitamin B complex, Vitamin D, folic acid, biotin, and selenium to provide balanced nutrition for children. Recognizing the se
- 김갑성 기자
- 2025-11-03 14:00
GC Biopharma's Recombinant Anthrax Vaccine, BARYTHRAX, De…

YONGIN, South Korea, Nov. 3, 2025 -- GC Biopharma, a leading global pharmaceutical company based in South Korea, announced today that the Phase 2 clinical trial results for its anthrax vaccine 'BARYTHRAX inj. (GC1109)' have been published in the international journal Vaccine. BARYTHRAX is the world's first recombinant anthrax vaccine, jointly developed by GC Biopharma and the Korea Disease Control and Prevention Agency (KDCA). This randomized, double-blind, placebo-controlled Phase 2 clinical trial, approved by the Ministry of Food and Drug Safety (MFDS) was condu
- 김갑성 기자
- 2025-11-03 13:26
Akeso's Ivonescimab Secures Fourth Breakthrough Therap…

HONG KONG, Nov. 3, 2025 -- Akeso (9926.HK) announced that its first-in-class bispecific antibody, ivonescimab (PD-1/VEGF bispecific antibody), in combination with chemotherapy for first-line treatment of triple-negative breast cancer (TNBC) has been granted Breakthrough Therapy Designation (BTD) by the Center for Drug Evaluation (CDE) from China's National Medical Products Administration (NMPA). The Phase III multicenter, randomized, double-blind clinical trial (HARMONi-BC1/AK112-308) for this combination therapy is ongoing in China. The BTD designation is expected to further expedite
- 김갑성 기자
- 2025-11-03 12:12
MALAYSIA HEALTHCARE TRAVEL COUNCIL STRENGHTENS REGIONAL PRE…

MEDAN, Indonesia, Nov. 3, 2025 -- The Malaysia Healthcare Travel Council (MHTC) continues to advance its regional outreach by participating in the ASTINDO Travel Fair (ATF) 2025, held in Medan, Indonesia. The event serves as one of the largest tourism exhibitions in the country, gathering travel agents, airlines, hotels, medical institutions, and tourism partners under one roof to showcase their offerings and foster cross-border collaboration. As part of the Malaysia Healthcare Pavilion, MHTC leads a delegation of nine (9) world-renowned Malaysian hospitals, further reinforcing
- 김갑성 기자
- 2025-11-03 11:37
OMANI PATIENTS GAIN DIRECT ACCESS TO MALAYSIAN MEDICAL SPECIALIS…

SEEB, Oman, Nov. 3, 2025 -- Malaysia Healthcare Week opens at City Centre Mall, Seeb, marking the first major Middle East activation under the Malaysia Year of Medical Tourism (MYMT) 2026. The week-long programme connects Omani patients with Malaysian medical specialists through public exhibitions, clinical consultations and professional exchange, demonstrating Malaysia's "Healing Meets Hospitality" approach to international healthcare. The initiative runs through 5 November in partnership with the Embassy of Malaysia in Oman. IHH Healthcare Group leads the Malaysian
- 김갑성 기자
- 2025-11-03 11:19
Oxford Instruments introduces the witec360 Raman Microsco…

LONDON, Nov. 3, 2025 -- Oxford Instruments today announced the launch of its witec360 Raman microscope with the Hexalight spectrometer, setting a new benchmark in confocal Raman imaging and analysis. The new system delivers unprecedented optical performance, automation, and flexibility for research institutions and advanced industries across Singapore and the wider Asia region. Building on the proven heritage of the WITec alpha300 series, the witec360 Raman microscope offers improved light transmission, enhanced automation, and an optimized confocal beam path from laser to dete
- 김갑성 기자
- 2025-11-03 09:00

이전

1 2 3 4 5 6 7 8 9 10

많이 본 기사

최근기사

2025-11-03_MON

발행인 : 최희정 | 편집인 : 김갑성 |
등록번호: 서울특별시 아53302 | 등록일 2020-09-25 | 전화번호 02-565-7119 |
주소 : 서울특별시 강남구 영동대로 602, 6층 E115 (삼성동)
Copyright @메디채널 Corp. All rights reserved.

UPDATE: 2025년 11월 03일 18시 40분